ORIC
Companies
NASDAQ
Oric Pharmaceuticals Inc.
Health Care
$10.51
+$2.44 (+30.17%)
Price Chart
Overview
About ORIC
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
Market Cap
$595.3M
Volume
9.8M
Avg. Volume
8.4M
P/E Ratio
-2.2364533
Dividend Yield
0.00%
Employees
93.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.84
Moderate Correlation
Volatility
High (0.80)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ORIC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$595.3M
Volume9.8M
P/E Ratio-2.24
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 19, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025